Board Member, Sociedad Argentina de Trasplantes (SAT)
MD, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina
Residency, General Surgery, Hospital General de Agudos “Dr. Cosme Argerich”, Buenos Aires, Argentina
Fellow, Transplant and Hepatobiliary Surgery, Recanati-Miller Transplant Institute, Mount Sinai Hospital, New York, NY, USA
Clinical Pancreas transplantation
Anti-HLA donor specific antibody monitoring in pancreas transplantation: Role of protocol biopsies. Uva P, Quevedo A, Roses J, Toniolo F, Pilotti R, Chuluyan E, Casadei. Clin Transplant 2020;34(8):e13998
Graft dysfunction in simultaneous pancreas kidney transplantation. Results of concurrent kidney and pancreas allograft biopsies. Uva P, Pappadimitriou JC, Drachenberg CB, Toniolo F, Quevedo A, Dotta A, Chuluyan E, Casadei D. Am J Transplant 2019;19:466-474.
Laparoscopic biopsies in pancreas transplantation. Uva P, Odorico J, Giunippero A, Cabrera I, Gallo A, Leon L, Minue E, Toniolo F, Gonzalez I, Chuluyan E, Casadei D. Am J Transplant 2017;17:2173-2177.
Director, Kidney and Pancreas Transplantation Medstar Georgetown Transplant Institute United States
Matthew Cooper is a Professor of Surgery at Georgetown School of Medicine and the Director of Kidney and Pancreas Transplantation at the Medstar Georgetown Transplant Institute (MGTI). After receiving his medical degree from the Georgetown University School of Medicine in 1994, Dr Cooper completed his general surgery training at the Medical College of Wisconsin followed by a fellowship in multi-organ abdominal transplantation in 2002 at the Johns Hopkins Hospital in Baltimore, MD. He joined the transplant faculty at the Johns Hopkins Hospital upon completion of his training and was appointed Surgical Director of Kidney Transplantation and Clinical Research in 2003. Dr. Cooper joined the University of Maryland in 2005 directing the kidney transplant and clinical research program until 2012 following which he assumed his current role in Washington, DC. Dr. Cooper trained with the pioneers of the laparoscopic donor nephrectomy procedure and seeks new opportunities for living donation through innovation and by removing the disincentives for those considering donation while promoting the safety and long-term care of live organ donors. His clinical interests included kidney and pancreas transplantation; particularly the use of marginal organs and has recently chaired a NKF sponsored Task Force to decrease kidney allograft discards which has led to several exciting projects to potentially bring more patients an opportunity for kidney transplantation. Dr. Cooper is involved in several ongoing clinical research projects primarily with an interest in immunosuppression minimization and amelioration of delayed graft function in kidney allografts following ischemic reperfusion injury. He has authored over 130 peer-reviewed manuscripts, 220 abstracts and 6 book chapters. He is regularly invited to speak on a variety of transplant-related topics both nationally and internationally. Dr. Cooper is involved in transplantation activities both locally in the District and on a national basis. He is a member of the National and DC Board of Directors for the NKF and a member of the NKF’s National Transplant Task Force and Public Policy Committee. He has served as the chairman of the United Network of Organ Sharing’s Living Donor Committee and recently acted as the Councillor for UNOS’ Region 2. He is a current councillor for the American Society of Transplant Surgeons. He is a current board member for the National Kidney Registry, the American Foundation for Donation and Transplantation, the International Pancreas and Islet Cell Transplant Association, Donate Life America and the local OPO – Washington Regional Transplant Community.
Scientific Program Committee
Isolation and Transplantation Center University of Geneva Switzerland
Thierry Berney, MD, MSc is a Professor of Surgery at the University of Geneva School of Medicine and an attending surgeon in the Division of Visceral and Transplantation Surgery at Geneva University Hospitals. He graduated from the University of Geneva School of Medicine in 1987 and specialized in Visceral Surgery in Switzerland. He further specialized in Transplantation Surgery in Brussels, Belgium and Miami, Florida, with a particular interest in islet, pancreas and small bowel transplantation. Since 2002, he is an attending surgeon in Visceral Surgery, with a focus on Pancreatic and Gastro-Intestinal Surgery. He is the head of the Cell Isolation and Transplantation Center, and the director of the Islet and Pancreas Transplant Programs in Geneva University Hospitals, which is one of the most active worldwide. He is a founding member of the Intestinal Transplant Association, and a member of several Surgical and Transplantation Societies.
Dr. Jonathan Fridell’s area of clinical practice is pancreas transplantation, either with a kidney transplant or alone, for patients with Type 1 diabetes with hypoglycemic unawareness. He is the chief of abdominal transplantation and surgical director of the IU Health pancreas transplant program, one of the highest volume programs in the country since 2007. He joined the Indiana University School of Medicine in 2002 where he is chief of the division of abdominal transplant surgery. Dr. Fridell has been involved in the growth of the pancreas and liver transplant programs and helped initiate the intestine/multivisceral transplant program at IU Health. Dr. Fridell is a native of Montreal, Canada, where he received his MD degree and surgical training at McGill University. He completed a transplant surgery fellowship at the Thomas E. Starzl Transplant Institute at the University of Pennsylvania. Dr. Fridell’s expertise and research interests include pancreas and liver transplantation. As a leader in his field, he is past chair of the United Network for Organ Sharing (UNOS) Pancreas Transplant Committee as well as associate editor of the American Journal of Transplantation and deputy editor of Clinical Transplantation.
Department of Endocrinology and Diabetes TU Dresden, Germany
Laurence Kessler is Professor of Endocrinology and Diabetology at Strasbourg University Hospitals. Her main interest is the management of type 1 diabetic patients and patients with secondary diabetes: post-transplantation and cystic fibrosis-related diabetes. She is particularly interested in the development of innovative therapies, including diabetes cell therapy, close loop insulin delivery and continuous glucose monitoring. She is head of the GRAGIL Swiss French pancreatic islet transplantation network. She is in charge of the Organ Dysfunction and Transplantation research group within the INSERM UMR 1260 unit at the University of Strasbourg, created in 2018. Her fundamental researches are focused on vascular and tissue stress in transplantation through the study of micro vesicles and cellular environment. Via the input of the MPs and the specific environment representing pancreatic islet transplantation, her research articulated around two axes: (i) the vascular alterations of islet graft and approaches for tissue repair (ii) the development of biomarkers for islet graft monitoring.
University of Wisconsin School of Medicine and Public Health United States
Dr. Odorico is Director of the Pancreas and Islet Cell Transplantation Programs and Professor in the Department of Surgery, Division of Organ Transplantation at the University of Wisconsin-Madison School of Medicine and Public Health. He received his Chemistry BS from Duke University, and M.D. from New York University. He completed General Surgery training as well as a post-doctoral research fellowship, at the University of Pennsylvania and Organ Transplant Fellowship at University of Wisconsin. Dr. Odorico has an active, extramurally funded research laboratory that focuses on beta cell differentiation from pluripotent stem cells. He has previously served as President of IPITA and Chair of the UNOS Pancreas Committee. He is also the scientific co-founder of Regenerative Medical Solutions, Inc.
Dr. Fabio Vistoli. MD, PhD graduated in Medicine at the University of Pisa, there, he obtained a Masters in Vascular Surgery, Residency in Surgery of the Digestive System and Ph.D. in Surgery, Immunology and Transplant Biotechnology He contributed to the description of an original surgical model of fulminant hepatitis in the pig useful for testing extracorporeal hepatic circulation systems and an original technique of abdominal organ harvesting en-bloc in humans. Since 1999 he has contributed to the development of the pancreas transplant program at the University of Pisa, which is currently the most active in Italy and one of the most active in Europe. In this field he contributed to the development of an original technique of retroperitoneal pancreas transplantation with portal-enteric drainage, he participated in the development of the applications of minimally invasive robot assisted surgery in kidney and pancreas transplants. In 2007-2008 he obtained a post-doc position in transplant immunology at the ITERT (Institut de Transplantation et de Recherche en Transplantation) in Nantes (France).He participated in the evolution of the pancreatic cancer surgery program of the University of Pisa, one of the most active in Italy, in which he helped to demonstrate the safety and usefulness of the duodenocefalopancreasectomy with venous resection and those of the robot-assisted minivase approach. He partecipated at the first european lapaorscopic robot-assisted kidney transplant (2009) and at the first worldwide laparoscopic robot assisted pancreas transplantation (2010). Dr. Vistoli serves as Associate Professor of Surgery at the University of Pisa, Pisa (Italy). He has obtained numerous national and international funding and awards, has conducted and participated in numerous prospective clinical trials in the field of transplantation and pancreatic cancer surgery.
We have carefully selected our presenters to provide the most relevant up-to-date curriculum possible.